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A B S T R A C T
Understanding the neural mechanisms underlying psychological therapy could aid understanding of recovery
processes and help target treatments. The dual-process model hypothesises that psychological therapy is asso-
ciated with increased emotional-regulation in prefrontal brain regions and decreased implicit emotional-re-
activity in limbic regions; however, research has yielded inconsistent ﬁndings. Meta-analyses of brain activity
changes accompanying psychological therapy (22 studies, n= 352) and neural predictors of symptomatic im-
provement (11 studies, n= 293) in depression and anxiety were conducted using seed-based d mapping. Both
resting-state and task-based studies were included, and analysed together and separately. The most robust
ﬁndings were signiﬁcant decreases in anterior cingulate/paracingulate gyrus, inferior frontal gyrus and insula
activation after therapy. Cuneus activation was predictive of subsequent symptom change. The results are in
agreement with neural models of improved emotional-reactivity following therapy as evidenced by decreased
activity within the anterior cingulate and insula. We propose compensatory as well as corrective neural me-
chanisms of action underlie therapeutic eﬃcacy, and suggest the dual-process model may be too simplistic to
account fully for treatment mechanisms. More research on predictors of psychotherapeutic response is required
to provide reliable predictors of response.
1. Introduction
Psychological interventions are ﬁrst-line treatments for depression
and anxiety disorders (Baldwin et al., 2014; Cleare et al., 2015; NICE,
2009) but are ineﬀective for as many as 50% of patients (Cuijpers et al.,
2014; Loerinc et al., 2015). Research investigating the neural correlates
of therapy aims to provide a greater understanding about the formation,
recovery and maintenance of symptoms, in addition to aiding the de-
velopment of improved treatments and personalised medicine ac-
cording to likely response (Lueken and Hahn, 2016), which could im-
prove outcomes for recipients of psychological interventions. Recent
reviews have highlighted the promise of functional neuroimaging stu-
dies in this ﬁeld for both depression and anxiety disorders (Fu et al.,
2013; Hamilton et al., 2012; Ma, 2015; Wise et al., 2014).
Neuroimaging studies take either a longitudinal approach, where
patients are scanned before and after therapy, or a predictive approach
where patients are scanned before therapy to determine pre-treatment
brain-level predictors of subsequent symptomatic improvement.
Longitudinal studies aim to identify changes in regional brain activity
that are associated with the therapeutic mechanisms of the interven-
tion. In contrast, prediction studies aim to provide a basis for stratiﬁed
treatment according to likely response, potentially enabling clinicians
to more eﬀectively tailor therapies to individual patients (Fu et al.,
2013). These complementary approaches may serve as a tool for clinical
decision-making, along with behavioural markers gained from them.
Functional neuroimaging studies (using magnetic resonance ima-
ging (MRI), single photon emission computed tomography (SPECT) or
positron emission tomography (PET) scanning) typically demonstrate
an imbalance in neural activation in patients with anxiety and de-
pression compared to healthy controls whereby abnormally elevated
limbic activation is not adequately controlled by prefrontal regions
(Etkin, 2010; Hariri et al., 2000; Rauch et al., 2000; Whalen et al.,
2002). These ﬁndings align with a dual-process model of emotion
regulation with top-down prefrontal controlled processes and bottom-
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up, automatic limbic activation (Barrett et al., 2004). Prefrontal areas
are involved in executive control (Owen et al., 2005) and emotional
regulation processes (Ochsner and Gross, 2005), and have an inhibitory
eﬀect on limbic brain regions such as the amygdala, insula, hippo-
campus and anterior cingulate cortex (ACC), which are associated with
intrinsic emotional reactivity (Drevets and Raichle, 1998; Phillips et al.,
2003).
Patients with aﬀective disorders who remit have been found to show
recovery in the imbalance between these two systems (DeRubeis et al.,
2008; Etkin et al., 2005; Siegle et al., 2007). DeRubeis et al. proposed
that psychological therapies for depression act to regulate emotional
control processes by increasing activation in prefrontal emotional reg-
ulation systems which in turn have a top-down eﬀect on limbic acti-
vation (DeRubeis et al., 2008). An equivalent model in anxiety dis-
orders has been proposed (Etkin et al., 2005).
There are, however, inconsistencies in the literature regarding the
speciﬁc brain regions and direction of activation changes within regions
(Goldapple et al., 2004; Linden, 2008) with some research being at odds
with the model; for example, ﬁndings of decreased pre-frontal activa-
tion following psychological therapy (Taylor and Liberzon, 2007).
Theoretically, this is not entirely unexpected as hyper-prefrontal acti-
vation has been associated with ruminative thinking (Goldapple et al.,
2004) and the intrusiveness of traumatic memories (Lindauer et al.,
2008) which would be expected to reduce with therapy.
For several reasons, ﬁndings from neuroimaging studies of treat-
ment response may not be robust when considered independently.
Results can be diﬃcult to integrate comprehensibly especially given
inconsistency in results and between study heterogeneity including
diﬀerences in eﬀect size caused by small sample sizes (Radua and
Mataix-Cols, 2012). Meta-analyses in the ﬁeld of neuroimaging provide
an eﬀective way to determine consistencies across datasets with im-
proved statistical power.
1.1. Aims and hypotheses
The aim of this study was to use meta-analyses to determine the
most robust changes with psychological therapy in two domains: 1)
functional brain activation changes from before to after psychological
therapy and 2) pre-treatment brain activation predictors of subsequent
symptomatic improvement in patients with depression or anxiety dis-
orders. To our knowledge this is the ﬁrst prediction meta-analysis
published in this ﬁeld across both depression and anxiety related dis-
orders. Both disorders were included due to high levels of comorbidity
between the conditions (Brown et al., 2001; Kaufman and Charney,
2000), overlapping symptoms, both responding to similar therapies
(Ressler and Mayberg, 2007), and the same theory being used to model
therapeutic response across disorders (Messina et al., 2013). Further,
meta-analyses across psychiatric disorders have found evidence of more
similarities in functional and structural neuroimaging abnormalities
across disorders than diﬀerences, despite variance in symptoms
(Goodkind et al., 2015; McTeague et al., 2017). Additionally, all psy-
chological therapies were considered due to evidence of commonalities
between therapies such as therapeutic alliance, the opportunity to ex-
press thoughts and gain understanding of the self (Luborsky et al.,
2002; Rosenzweig, 1936; Wampold et al., 2002).
Analyses were conducted using anisotropic eﬀect-size seed-based d
mapping (AES-SDM). This is similar to the more widely used neuroi-
maging meta-analytic technique called activation likelihood estimation
(ALE, http://brainmap.org/ale); however, AES-SDM is able to provide a
more accurate estimation of signal due to accounting for eﬀect size in
calculations (Radua et al., 2012). AES-SDM also has the advantage of
permitting analysis of heterogeneity between studies via meta-regres-
sions, and addresses between-study heterogeneity by counteracting the
eﬀects of studies reporting opposite activation ﬁndings in the same
region by reconstructing both positive and negative maps in the same
image (Radua et al., 2012).
We applied a thorough and conservative approach to identify the
most robust ﬁndings within this heterogeneous literature. In line with
the dual-process model, we hypothesised that psychological therapy
would be associated with increased prefrontal activity and reduced
limbic activity post- compared to pre-therapy. We hypothesised that
increased baseline ACC activation would be predictive of greater
symptomatic improvement in accordance with results from a meta-
analysis primarily of pharmacological treatment prognostic neural
biomarkers (Fu et al., 2013) and a recent review of neuroimaging
predictors of response in anxiety and depression (Lueken and Hahn,
2016).
2. Methods and materials
2.1. Literature searches and study selection
Literature searches were conducted in the following electronic da-
tabases: Scopus (Elsevier, http://www.scopus.com), PubMed (https://
www.ncbi.nlm.nih.gov/pubmed/) and Medline (Ovid Technologies
Inc., http://ovidsp.uk.ovid.com) to identify articles published before
24.07.2017. The searches identiﬁed studies using MRI, SPECT or PET.
All retrieved articles were evaluated for suitability. Reference lists of
included articles and relevant reviews were manually searched.
The following eligibility criteria were applied:
• Articles were excluded if they did not include subjects meeting
Diagnostic and Statistical Manual (DSM) or International
Classiﬁcation of Disease (ICD) (American Psychiatric Association,
2013; World Health Organization, 1993) diagnostic criteria for
major depressive disorder (MDD); bipolar disorder; dysthymia; ob-
sessive compulsive disorder (OCD); post-traumatic stress disorder
(PTSD); panic disorder; social anxiety disorder (SAD); generalised
anxiety disorder (GAD); or speciﬁc phobia (SP).
• Studies looking at the above aﬀective disorders alongside neurolo-
gical conditions were excluded to ensure ﬁndings were not obscured
by neurological pathology.
• Participants were required to have been scanned prior to beginning
a course of psychological therapy and have examined pre-treatment
regional brain activation in relation to post-treatment change in
symptom severity (prediction studies) or brain activity changes pre-
to post-therapy (longitudinal studies). Studies were not excluded on
the basis of concomitant psychotropic medication.
• Articles were excluded if they were case reports, reviews, meta-
analyses, or not written in English.
• Only adult samples were suitable; studies focused on child, adoles-
cent or geriatric populations were excluded to minimise the eﬀect of
neurodevelopmental and neurodegeneration confounders. In ger-
iatric populations, there is an increased likelihood that organic
disorders underlie, contribute to or confound depressive symptoms.
Older patients are therefore likely to show age-speciﬁc neuroima-
ging correlates of therapy (Aizenstein et al., 2014; Smith et al.,
2009). In adolescents, neurodevelopmental features need to be
taken into account and inconsistencies have been found between
adolescent and adult ﬁndings (Kerestes et al., 2014).
• Only whole brain results were included. Articles that used a region
of interest (ROI) or machine learning approach only, did not apply
consistent statistical thresholds throughout the brain (for example,
regional resting-state analysis methods such as seed-based analyses),
or did not report peak coordinates in stereotactic space were ex-
cluded.
• Both task-based and resting-state functional scanning paradigms
were included. In order to control for any possible diﬀerences ob-
served between these two study types, standard AES-SDM meta-
analyses were conducted separately for task-based and resting-state
studies and a meta-regression conducted controlling for paradigm
type to increase methodological homogeneity where the number of
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studies permitted. This approach was taken as functional paradigm
type can aﬀect results and regions of activation (Fu et al., 2007;
Messina et al., 2013; Palmer et al., 2015; Whitﬁeld-Gabrieli et al.,
2011).
• To ensure no overlap between studies, in the case of multiple studies
reporting the same patient group, we included the largest sample or,
in studies following up the same participant group at a range of time
points post-therapy, the study reporting scanning at the time-point
closest to therapy completion.
2.2. Meta-analyses
Analyses were carried out using AES-SDM (Version 5.141, 38). AES-
SDM is a voxel-based, weighted meta-analytical method which creates
voxel-level maps based on eﬀect size and variance of peak-coordinates
reported within studies and analyses them with random-eﬀects meta-
analytic methods. T-statistics are converted to eﬀect sizes using stan-
dard statistical techniques. Eﬀect size is calculated exactly at the re-
ported peak coordinates and estimated, depending on distance from the
peak, for the surrounding voxels using an anisotropic un-normalised
Gaussian kernel multiplied by the eﬀect size of the peak, subject to
tissue-type constraints.
As suggested by Radua and Mataix-Cols (2012), voxels with a p-
value< .005 were considered as signiﬁcant, but those from clusters
with fewer than 10 voxels or peaks with AES-SDM Z-values< 1 were
discarded to reduce the false positive rate. To determine the most ro-
bust results and explore the inﬂuence of outliers, a jackknife sensitivity
analysis was conducted to assess the contribution of individual studies
to the overall results. This repeats the analyses removing one study per
iteration. Results were excluded that did not remain signiﬁcant in 10%
or more of iterations. To assess publication bias, funnel plots of eﬀect
size estimates of peak voxels were visually inspected and an Egger re-
gression test implemented to examine funnel plot asymmetry (Egger
et al., 1997). This was conducted using the metafor package for R
software (Viechtbauer et al., 2010) (http://www.r-project.org/). The
potential eﬀect of paradigm type (task versus resting state scans) was
examined by simple linear models and repeating standard AES-SDM
meta-analyses in subgroups.
3. Results
3.1. Literature searches
Scopus returned 3,559, PubMed 673 and Medline 958 results. From
these, 33 articles were suitable for inclusion in analyses (see Fig. 1).
3.2. Longitudinal results
Twenty-two longitudinal studies (n= 352 patients) met eligibility
criteria and were included in this analysis (see Table 1 for study de-
tails). The studies comprised the following patient groups: PD (n=5);
PTSD (n= 4); social anxiety disorder (n=5); unipolar MDD (n=3);
SP (n= 2); OCD (n= 2); and GAD (n= 1). Disorder severity was ty-
pically in the moderate range (Table 1).
Table 2 provides details of all signiﬁcant clusters from the long-
itudinal studies (n= 22). Details of jackknife sensitivity analysis, visual
inspection of funnel plots, and publication bias analyses are detailed in
the table. All regions survived sensitivity analysis and Eggers regression
(all ps> .05), though some regions showed signs of publication bias in
visual inspection of funnel plots. The most robust results, with no evi-
dence of publication bias, were that psychological therapy was asso-
ciated with signiﬁcantly decreased activity post- compared to pre-
therapy, in the left ACC/paracingulate gyri, the right inferior frontal
gyrus and left inferior frontal gyrus/insula (all ps< .0001) (see Fig. 2).
Too few studies met our eligibility criteria to perform meta-regres-
sions to explore heterogeneity between disorders, concomitant
medication status or therapy type (Radua et al., 2010). AES-SDM ana-
lyses were repeated and limited to task (n= 17) and resting-state stu-
dies (n=5). The separate analyses showed that the clusters found
overall (see Table 2) in the corpus callosum and left ACC/paracingulate
gyri remained consistent across both subgroups (see Tables 3 and 4).
The right inferior network (p= .0003, peak coordinates: 22,−60,−8),
right arcuate network (p= .0004, peak coordinates: 40, −60, 20), bi-
lateral inferior frontal gyri and right middle frontal gyrus (p= .00005,
peak coordinates: 48, 34, 18) ﬁndings were only found in resting-state
studies. Left inferior frontal gyrus (p < .0001 peak coordinates: -50,
10, 14) and left insula (which came as an additional separate cluster for
task-based studies, p= .003, peak coordinates:−38, 0,−10) and right
temporal pole/mid temporal gyrus (p= .003, peak coordinates: −46,
4, −34) were signiﬁcant ﬁndings in task-based analysis only. This was
conﬁrmed with a linear model conﬁrming signiﬁcant diﬀerences in task
versus resting-state in these regions.
Regarding task-based longitudinal analysis, all but one region sur-
vived jackknife analysis criteria (the right temporal pole/middle tem-
poral gyrus, p= .003, peak coordinates: −46, 4, −34, see Table 3).
The most robust ﬁndings were the precuneus increased activation
(p= .0002, peak coordinates: 6, −56, 38) and ACC deactivation
(p= .0001, peak coordinates: −8, 44, −2) post-therapy, which
showed no signs of publication bias.
None of the resting-state only clusters showed signs of publication
bias (see Table 4). Due to few studies meeting eligibility for this analysis
(n= 5), the only cluster meeting our criteria for robustness, surviving
all iterations of the jackknife sensitivity analysis, was the right middle
frontal gyrus (p= .00005, peak coordinates 48, 34, 18).
3.3. Prediction results
Eleven whole brain pre-treatment neuroimaging prediction studies
(n= 293 patients) meeting eligibility criteria were included in this
analysis (see Table 5 for study descriptions). All studies had analysed
pre-treatment neural activation in relation to change in scores on
measures of symptom severity. The studies comprised the following
patient groups: PTSD (n=2); SAD (n=5); OCD (n=2); MDD (n=1)
and PD (n=1).
Only one cluster survived jackknife sensitivity analysis (a cluster
with peak coordinates in the right cuneus cortex (p= .0004, peak co-
ordinates: 10,−92, 14) which extended into the right superior occipital
gyrus and right middle occipital gyrus); jackknife analysis revealed the
other clusters were not robust (see Table 6). Evidence of publication
bias was observed in all clusters’ funnel plots which was supported an
Egger’s regression test with trend signiﬁcance for the cluster of de-
creased activation (t(1, 10) = −2.17, p= .055) (See Fig. 2).
There were too few studies that met our eligibility criteria to per-
form meta-regressions (Radua et al., 2010) to study heterogeneity be-
tween disorders, therapies or methodologies (all but one study was
task-based). When the meta-analyses was re-run on only studies which
had used a task during scanning (n=10), the four signiﬁcant clusters
as per the original analysis remained unchanged.
4. Discussion
These meta-analyses demonstrate that psychological therapy has
robust eﬀects on brain function and predicts therapeutic response
across anxiety and depression, and provides partial support for the dual
process model. Since the publication of similar reviews and meta-ana-
lyses (for example, (Brooks, 2015; Fu et al., 2013; Lueken and Hahn,
2016; Messina et al., 2013) the ﬁeld has expanded rapidly, and the
present study provides the largest and most up-to-date summary of the
literature. Additionally, we used an improved analysis method which
has various strengths compared to other neuroimaging meta-analytical
techniques (Radua et al., 2014) and implemented a thorough and
conservative approach to identify only the most robust studies within
L. Marwood et al. Neuroscience and Biobehavioral Reviews 95 (2018) 61–72
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this heterogeneous literature ﬁtting our eligibility criteria.
4.1. Longitudinal ﬁndings
The most robust ﬁndings were that psychological therapies resulted
in decreased activation, post- compared to pre-therapy, in clusters with
peak co-ordinates in the left ACC, inferior frontal gyrus (bilaterally) and
left insula. It is important to note that studies had typically included
both responders and non-responders in their analyses and therefore the
changes are not indicative solely of treatment response. Due to our
jackknife analyses, which indicated evidence of consistency in the
ﬁndings across studies, the results appear to show brain activation
changes which are consistent across psychological therapies and are
trans-diagnostic. However, it is important to highlight that these ﬁnd-
ings do not signify that there are not activation changes that are speciﬁc
to types of psychological therapy or able to diﬀerentiate between dis-
orders and their subtypes. There were currently, however, too few
studies to study disorder- or treatment-speciﬁc brain activation
changes. Additionally, it would be diﬃcult to conﬁdently study one
disorder in isolation from another due to high levels of comorbid Axis I
disorders in the patient samples (see Tables 1 and 5).
The analyses were run separately on task and resting-state studies
due to evidence that paradigm type can eﬀect results (Fu et al., 2007;
Messina et al., 2013; Palmer et al., 2015; Whitﬁeld-Gabrieli et al.,
2011). Our subgroup analysis revealed substantial diﬀerences between
these paradigms; however, a decrease in ACC activity post-therapy was
a common ﬁnding across both resting-state and activation paradigms.
This result is in agreement with a recently published systematic review
on brain activation changes with CBT summarising that the most con-
sistent ﬁnding is decreased dorsal ACC activity (Franklin et al., 2016).
This region is involved in both emotional processing and regulation and
has been linked to self-referential processing and cognitive and atten-
tional control with strong connections to both limbic and prefrontal
brain regions (Pizzagalli, 2011).
We did not ﬁnd dlPFC involvement despite this region also being
associated with attentional control and emotional regulation (Hofmann
et al., 2012; Kane and Engle, 2002; Owen et al., 2005; Wager and
Smith, 2003). This could be due to an insuﬃcient number of studies in
our meta-analyses to demonstrate this eﬀect and an inconsistency be-
tween the designs of included studies. We did however ﬁnd signiﬁcant
eﬀects elsewhere in prefrontal brain regions, including the IFG which is
a key region involved in emotional regulation and inhibition (Aron
et al., 2003, 2004) which suggests involvement of the PFC in aﬀective
disorders may be complex and not attributable to a single region
(Fitzgerald et al., 2006; Thomas and Elliott, 2009).
4.2. Implications for the dual-process model
The dual-process model is appealing due to its parsimony and ﬁtting
with the theoretical modes of action we would expect from treatments
for aﬀective disorders. For example, CBT is proposed to improve emo-
tional regulation by challenging negative cognitions and improving
conscious emotional regulation. We would therefore expect greater
cognitive control to be evident in prefrontal conscious emotional-reg-
ulation brain regions. The decreased activation we found in limbic re-
gions (the ACC and insula) is consistent with this emotional regulation
model of depression and anxiety. However, the decreased activation we
found bilaterally in the inferior frontal gyrus runs counter to this, as the
theory proposes increased activation in pre-frontal regions, associated
with emotional regulation.
Despite these ﬁndings being at odds with the model, they do not
necessarily undermine its credibility. Decreased prefrontal activity,
particularly in resting-state studies, may signify an enhanced capacity
for top-down regulation when required i.e., these areas were dysregu-
lated but regained the capacity to respond appropriately and are ‘better’
utilised when necessary after psychological therapy.
However, the model may be too simplistic as it ignores any com-
pensatory changes in functioning that may be occurring. This more
complex model has been proposed by Willner et al. (2013) in relation to
the mode of action of antidepressants, but we suggest that there are
likely to be compensatory as well as normalising mechanisms involved
with psychological therapies also.
Fig. 1. Flowchart of process of publication selection.
Abbreviations – ROI, Region of Interest.
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Additionally, it is unlikely that the eﬀects of psychological therapies
can be solely represented by cognitive control and voluntary emotional
regulation with a linear relationship between prefrontal and limbic
regions. Messina et al. proposed an alternative neural model of action of
psychological therapy, albeit with a focus on psychodynamic therapy
models (Messina et al., 2016). They highlighted that the dual-process
model ignores that psychodynamic therapy aims to regulate emotional
states, not only by strengthening executive control but through the
resolution of early childhood parental interactions and challenging
negative representation of the self and others in relationships. They
therefore postulated that one should expect direct changes in default
mode network and implicit emotional regulation regions which are
involved in self-referential processing. Their model may also be ap-
plicable to other psychological therapies which also place importance
on challenging negative self-views.
4.3. Comparison to antidepressants
The neural eﬀects of psychological therapy are vastly understudied
compared to those of antidepressants. Ma conducted a meta-analysis of
the neural correlates of antidepressants which included 60 studies
(n= 1,569) (Ma, 2015) and found decreased activation in the ACC,
amygdala and thalamus with antidepressant medication and increased
activation in the dlPFC. These results ﬁt the dual-process model which
hypothesises that antidepressants act more directly on the emotional,
limbic network whereas psychological therapies primarily target pre-
frontal function by increasing inhibitory executive function. However,
we found evidence of reduced activity in limbic areas with psycholo-
gical therapies and therefore diﬀerentiation between treatment mod-
alities may be more complex than proposed. Further work directly
comparing treatment modalities is required to explore how far changes
reﬂect general as opposed to treatment-speciﬁc modes of recovery.
Table 2
Regions of signiﬁcant diﬀerence in brain activation change pre-to post-treatment.
Regions Peak MNI coordinate SDM
Z-value
p Number voxels BA
Neural activation: Post- > Pre-therapy
Right inferior network, inferior longitudinal fasciculus1 30, -62, -4 1.05 0.0007 118 –
Right arcuate network, posterior segment2 40, -54, 22 1.02 0.0008 82 –
Corpus callosum1 28, -62, 10 1.02 0.0008 19 –
Neural activation: Post- < Pre-therapy
Left anterior cingulate / paracingulate gyri* −2, 44, 4 −1.98 <0.0001 1548 10
Left inferior frontal gyrus, opercular part, left insula3 −50, 10, 14 −1.91 <0.0001 775 44
Right inferior frontal gyrus, triangular part* 48, 32, 20 −1.92 <0.0001 761 45
Left middle frontal gyrus4 −30, 52, 6 −1.30 0.001 101 10
Right temporal pole, middle temporal gyrus5 46, 4, -34 −1.20 0.002 64 20
Right middle frontal gyrus, orbital part4 26, 48, -14 −1.17 0.003 37 11
MNI, Montreal Neurological Institute; SDM, seed-based d mapping; BA, Brodmann Area. *Clusters surviving all tests of robustness and publication bias. 1 Driven only
by two studies Goldin and Gross (2010) and Yamanishi et al. (2009) and funnel plots showed evidence of publication bias in this cluster. 2 Driven only by Yamanishi
et al. (2009). 3 Driven by one study: Kircher et al. (2013). 4 Driven only by two studies: Goldapple et al. (2004) and Yamanishi et al. (2009) and a funnel plot showed
evidence of publication bias in this cluster. 5 Driven by two studies: Kircher et al. (2013) and Prasko et al. (2004) and a funnel plot showed signs of publication bias in
this cluster.
Fig. 2. A) Results of longitudinal meta-analysis showing brain activation change pre-to post-treatment B) Results of prediction meta-analysis, regions predicting
symptomatic improvement.
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Studies with a more frequent follow-up throughout the course of
treatment would enable us to more rigorously test the dual-process
model to determine whether diﬀerential primary actions between
treatment modalities exist. Additionally, work using dynamic causal
modelling of fMRI data or transcranial magnetic stimulation could
further allow us to determine the causal direction of results.
4.4. Prediction ﬁndings
In terms of the prediction data, we found one area, the right cuneus
cortex, whose greater activation at baseline was associated with greater
symptomatic improvement. This extrastriate region has been implicated
in response inhibition in particular those involving motor reactions
(Booth et al., 2005; Matthews et al., 2005). The cuneus forms part of the
DMN, which has been found to be abnormally activated in depression
(Greicius et al., 2009). However, there is inconsistency between study
results and too few published studies at present to determine further
robust predictors of symptomatic improvement with psychological
therapy. Speculatively, this could imply that prediction is more disorder
or treatment speciﬁc but further work is required to test this.
We hypothesised that increased baseline ACC activation would be
associated with symptomatic improvement in line with previous re-
views (Fu et al., 2013; Lueken and Hahn, 2016). We did ﬁnd that ele-
vated left ACC activation was associated with greater symptomatic
improvement; however, this region did not meet our criteria for ro-
bustness. Lueken and Hahn (2016) note in their systematic review that
the direction of predictive eﬀects of ACC activity was dependent both
on the type of functional imaging paradigm used and on the speciﬁc
psychological treatment received (Lueken and Hahn, 2016). Therefore,
ACC activation could have been masked in this meta-analysis. Cur-
rently, however, there were too few studies to explore the eﬀects of
between-study heterogeneity on this analysis.
4.5. General strengths and limitations
Although these meta-analyses present a comprehensive summary of
the evidence-base so far, the results should be considered cautiously.
The present literature is small meaning the inﬂuence of between study
heterogeneity, other than paradigm type, could not be assessed through
meta-regressions.
Between study heterogeneity could have inﬂuenced the results of
these analyses in several ways. Firstly, all functional neuroimaging
designs were included ranging from resting-state to emotionally dis-
tressing or cognitively demanding tasks. Although we did control for
resting-state versus task-based methodology to increase speciﬁcity in
ﬁndings, even the type of task can have a great eﬀect on the neural
activation detected (Fu et al., 2007; Palmer et al., 2015). By adopting
inclusive eligibility criteria for paradigm type, this will have increased
power given the paucity of research in this ﬁeld and allowed greater
generalisability of global results to broad neurobiological models.
Secondly, the included studies comprised patients with a range of dis-
orders, comorbidities, and symptom severity, another source of be-
tween- and within-study variability. Anxiety disorders were over-re-
presented compared to depression. Thirdly, we would expect that the
speciﬁc neural changes occurring with therapy would diﬀer according
to the type of psychological therapy the patient received (for example
as has been found with studies directly comparing diﬀerent therapies
(Burklund et al., 2017; Månsson et al., 2013). Additionally, the studies
varied on the concomitant psychotropic medication status of the pa-
tients (see Tables 1 and 5) which reduced our ability to conclude that
the neuroimaging eﬀects are solely due to psychological therapy.
However, most studies required patients to have been on the medica-
tion for an adequate trial (typically 6 or more weeks) and the medi-
cation to be kept stable for the duration of the study. Finally, we in-
cluded SPECT, PET and fMRI scanning methodologies. These methods
diﬀer in their measurement of brain activity, including temporal and
spatial resolution. Therefore, it is plausible that ﬁndings from the var-
ious modalities could diﬀer considerably. However, all included PET
and SPECT studies used radiotracers to measure regional brain glucose
metabolism, which is the measurement most related to fMRI BOLD
signal. Additionally, we only included studies where participants ful-
ﬁlled diagnostic criteria. Although warranted given the scope of these
meta-analyses the results may not be generalisable to all individuals
who evidence subthreshold clinical anxiety or depression. Despite
considerable heterogeneity, patients in the included studies were typi-
cally in the moderate to severe range of severity, most therapies were
cognitive and/or behavioral in nature, and a negative emotional scan-
ning paradigm was primarily used.
Another limitation is that we only included results of the patient
Table 3
Regions of signiﬁcant diﬀerence in brain activation change pre-to post-treat-
ment– task-based studies only.
Regions Peak MNI
coordinate
SDM
Z-value
p Number
voxels
BA
Neural activation: Post- > Pre-therapy
Right and left precuneus
/ corpus callosum1*
6, -56, 38 1.19 0.0002 995 7/23
Neural activation: Post- < Pre-therapy
Left inferior frontal
gyrus, opercular
part2
−50, 10, 14 −1.80 < 0.0001 576 44
Left anterior cingulate /
paracingulate gyri /
right anterior
cingulate 3*
−8, 44, -2 −1.67 0.0001 504 10
Left insula2 −38, 0, -10 −1.21 0.003 66 48
Right temporal pole,
middle temporal
gyrus4
−46, 4, -34 −1.21 0.003 64 20
Abbreviations - MNI, Montreal Neurological Institute; SDM, seed-based d
mapping; BA, Brodmann Area. N=274. *Clusters surviving all tests of robust-
ness. 1 Driven by one study: Goldin et al. (2012) and funnel plot showed signs
of publication bias. 2 Driven by one study Kircher et al. (2013) and eggers
regression test showed signs of publication bias. 3Driven by one study (Kircher
et al., 2013). 4 Driven by two studies (Kircher et al., 2013; Heide Klumpp et al.,
2013).
Table 4
Regions of signiﬁcant diﬀerence in brain activation change pre-to post-treat-
ment – resting-state studies only.
Regions Peak MNI
coordinate
SDM
Z-value
p Number
voxels
BA
Neural activation: Post- > Pre-therapy
Right lingual gyrus / right
inferior network, right
fusiform gyrus1
22, -60, -8 1.62 0.0003 686 19
Right arcuate network,
posterior segment1
40, -60, 20 1.61 0.0004 232 –
Corpus callosum1 26, -64, 14 1.50 0.001 23 –
Neural activation: Post- < Pre-therapy
Right middle frontal gyrus
right inferior frontal
gyrus *
48, 34, 18 −2.51 0.00005 949 45
Left middle frontal gyrus 1 −34, 56, 10 −2.30 0.00007 565 10
Right middle frontal gyrus,
orbital part1
30, 46, -18 −2.31 0.00006 279 11
Right anterior cingulate /
paracingulate gyri /
left anterior cingulate1
4, 50, 12 −2.13 0.0002 250 32
MNI, Montreal Neurological Institute; SDM, seed-based d mapping; BA,
Brodmann Area. N=78.
*Cluster surviving all tests of robustness. 1 Driven by one study (Yamanishi
et al., 2009).
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group who received therapy. Care should be taken when considering
the results of these meta-analyses, and indeed studies in this area, as
eﬀects are unlikely to be solely attributable to the treatment under
investigation and may in part be due to spontaneous remission or
concomitant therapy. This problem could be ameliorated by the in-
clusion of a placebo arm (for example, one-to-one non-therapy sessions
or wait-list control groups). Although fully balanced designs, with
control groups who also receive scans at both time points, are best
practice in order to properly model the eﬀect of repeated scans and
other non-treatment related factors (Dichter et al., 2012), including
only these studies was not within the scope of these meta-analyses in
order to maximise the number of suitable studies.
Additionally, as with all meta-analyses, the potential inﬂuence of
publication bias should be considered when interpreting results.
Although, in our longitudinal meta-analysis, we did not show any evi-
dence of this, there were signs of publication bias in the prediction of
treatment response meta-analysis. Also, our reliance on including only
peak co-ordinates reported in published papers does not provide the
level of detail that statistical parametric maps or individual-level data
would.
Despite considerable variability in study designs which these meta-
analyses illustrate, commonalities did emerge, and we were able to
demonstrate some consistent ﬁndings. In order to enhance the dis-
covery of brain-biomarkers of response and therapeutic action, future
studies should include larger samples and work to consistent study
designs and analytical techniques.
In conclusion, our meta-analyses demonstrate that there are con-
sistent brain activation changes in psychological therapy across de-
pression and anxiety disorders, although the literature is relatively
small and there is considerable between-study heterogeneity. However,
neural changes that are robustly predictive of treatment response re-
main elusive. We suggest that more research is required to form deﬁ-
nitive conclusions in order to beneﬁt patients at an individual level by
tailoring treatment according to likely response and understanding
treatment mechanisms in order to improve treatments.
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